Lawrence C. Swayne
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Monoclonal and Polyclonal Antibodies Research
- Medical Imaging Techniques and Applications
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Radiopharmaceutical Chemistry and Applications 14
- Radiology practices and education 5
- Radiation Dose and Imaging 5
- Monoclonal and Polyclonal Antibodies Research 4
- Surgery 26
- Hemodynamic Monitoring and Therapy 3
- Co-authors
- Robert M. Sharkey (12 shared papers)Malik E. Juweid (10 shared papers)David M. Goldenberg (12 shared papers)Thomas M. Behr (7 shared papers)Robert M. Dunn (7 shared papers)Malik Juweid (5 shared papers)George Hajjar (3 shared papers)Alexandra Rubin (5 shared papers)
- Journals
- Cancer (4 papers)Journal of the American College of Radiology (4 papers)Journal of Ultrasound in Medicine (3 papers)Radiology (3 papers)Journal of Computer Assisted Tomography (3 papers)
- Partner nations
- United StatesSpainPoland
In The Last Decade
Lawrence C. Swayne
75 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 89
- Radiology, Nuclear Medicine and Imaging 648
- Pathology and Forensic Medicine 224
- Oncology 241
- Endocrinology, Diabetes and Metabolism 140
- Surgery 319
Countries citing papers authored by Lawrence C. Swayne
This map shows the geographic impact of Lawrence C. Swayne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence C. Swayne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence C. Swayne more than expected).
Fields of papers citing papers by Lawrence C. Swayne
This network shows the impact of papers produced by Lawrence C. Swayne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence C. Swayne. The network helps show where Lawrence C. Swayne may publish in the future.
Co-authors
The 25 scholars most cited alongside Lawrence C. Swayne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pharmacokinetics, dosimetry, and initial therapeutic results with 131I- and (111)In-/90Y-labeled humanized LL2 anti-CD22 monoclonal antibody in patients with relapsed, refractory non-Hodgkin's lymphoma. | 1999 | 101 |
| 2 | Treatment of non-Hodgkin's lymphoma with radiolabeled murine, chimeric, or humanized LL2, an anti-CD22 monoclonal antibody. | 1995 | 99 |
| 3 | Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG. | 1997 | 90 |
| 4 | Evaluation of a complementarity-determining region-grafted (humanized) anti-carcinoembryonic antigen monoclonal antibody in preclinical and clinical studies. | 1995 | 73 |
| 5 | 1989 | 67 | |
| 6 | 1999 | 62 | |
| 7 | 1993 | 55 | |
| 8 | 2001 | 49 | |
| 9 | 1996 | 48 | |
| 10 | Radioimmunotherapy of patients with small-volume tumors using iodine-131-labeled anti-CEA monoclonal antibody NP-4 F(ab')2. | 1996 | 47 |
| 11 | Radioimmunotherapy of medullary thyroid cancer with iodine-131-labeled anti-CEA antibodies. | 1996 | 46 |
| 12 | Initial experience with high-dose radioimmunotherapy of metastatic medullary thyroid cancer using 131I-MN-14 F(ab)2 anti-carcinoembryonic antigen MAb and AHSCR. | 2000 | 45 |
| 13 | Pharmacokinetics, dosimetry and toxicity of rhenium-188-labeled anti-carcinoembryonic antigen monoclonal antibody, MN-14, in gastrointestinal cancer. | 1998 | 42 |
| 14 | Septic arthritis of a lumbar facet joint: detection with bone SPECT imaging. | 1989 | 37 |
| 15 | 1992 | 32 | |
| 16 | 1997 | 28 | |
| 17 | 1986 | 28 | |
| 18 | 1996 | 26 | |
| 19 | Gallbladder perforation: correlation of cholescintigraphic and sonographic findings with the Niemeier classification. | 1990 | 19 |
| 20 | 1984 | 19 |
About Lawrence C. Swayne
Lawrence C. Swayne is a scholar working on Radiology, Nuclear Medicine and Imaging, Surgery, Pulmonary and Respiratory Medicine, Oncology and Endocrinology, Diabetes and Metabolism, having authored 77 papers that have together received 1.4k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (14 papers), Medical Imaging and Pathology Studies (8 papers), Radiology practices and education (5 papers), Thyroid Cancer Diagnosis and Treatment (5 papers), Radiation Dose and Imaging (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Hemodynamic Monitoring and Therapy (3 papers) and Cardiac tumors and thrombi (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (648 citations), Pathology and Forensic Medicine (224 citations), Oncology (241 citations), Endocrinology, Diabetes and Metabolism (140 citations) and Surgery (319 citations). Lawrence C. Swayne has collaborated with scholars based in United States, Spain and Poland. Frequent co-authors include Robert M. Sharkey, Malik E. Juweid, David M. Goldenberg, Thomas M. Behr, Robert M. Dunn, Malik Juweid, George Hajjar, Alexandra Rubin, Jeffry A. Siegel and Jerry Shevitz. Their work appears in journals such as Cancer, Journal of the American College of Radiology, Journal of Ultrasound in Medicine, Radiology and Journal of Computer Assisted Tomography.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.